“…It has well been established that conditioned fear or drug seeking behavior is eradicated by being replaced by subsequent learning of harmless or alternative cues. This extinction phenomena have been applied as the behavioral therapies to the treatment of phobias, obsessive-compulsive disorder, posttraumatic stress disorder (PTSD) or drug abuse, and have newly been shown to be facilitated by the NMDA receptor glycine site agonists in their animal models [167][168][169][170][171][172]. In several randomized placebo-controlled clinical trials for phobia [173], social anxiety disorder [174], obsessive-compulsive disorder [175], PTSD [176] or panic disorder [126], low dose of d-cycloserine, a partial agonist for the glycine site of the NMDA receptor, in combination with a conventional cognitive behavioral therapy (CBT) has been reported to be more effective in ameliorating fear or anxiety compared with CBT alone.…”